Korean J Pediatr Infect Dis.  2012 Aug;19(2):79-83.

A Case of Reye Syndrome Following Treatment of Kawasaki Disease with Aspirin

• Lee JK
• Kang JE
• Choi EH
• Choi JY

Abstract

Reye syndrome is a rapidly progressive encephalopathy with hepatic dysfunction, which often begins several days after apparent recovery from a viral illness, especially varicella or influenza A or B. Salicylate use was identified as a major precipitating factor for the development of Reye syndrome. With the recommendation to avoid use of salicylates in children, Reye syndrome has virtually disappeared in recent years. We report a case of Reye syndrome in a 5-month-old infant who had been treated with intravenous immunoglobulin and aspirin under the diagnosis of Kawasaki disease, and showed symptoms of sudden onset of irritability, rigidity, decreased activity, vomiting, poor appetite, lethargy, liver dysfunction without jaundice, coagulopathy, and hyperammonemia.

Keyword

Kawasaki Disease; Reye Syndrome; Aspirin

MeSH Terms

Appetite
Aspirin
Chickenpox
Child
Humans
Hyperammonemia
Immunoglobulins
Infant
Influenza, Human
Jaundice
Lethargy
Liver Diseases
Mucocutaneous Lymph Node Syndrome
Precipitating Factors
Reye Syndrome
Salicylates
Vomiting
Aspirin
Immunoglobulins
Salicylates

Reference

1. De Vivo DC. Reye syndrome. Neurol Clin. 1985. 3:95–115.

2. Hardie RM, Newton LH, Bruce JC, Glasgow JF, Mowat AP, Stephenson JB, et al. The changing clinical pattern of Reye's syndrome 1982-1990. Arch Dis Child. 1996. 74:400–405.

3. Waldman RJ, Hall WN, McGee H, Van Amburg G. Aspirin as a Risk Factor in Reye's Syndrome. JAMA. 1982. 247:3089–3094.

4. Kim KH, Lee BH, Lee MI, Ahn DH, Sohn KC. Clinical Observation on Reye syndrome According to the Onset of Age in Children. J Korean Pediatr Soc. 1992. 35:788–794.

5. Chow EK, Castrillo A, Shahangian A, Pei L, O'Connell RM, Modlin RL, et al. A role for IRF3-dependent RX-Ralpha repression in hepatotoxicity associated with viral infections. J Exp Med. 2006. 203:2589–2602.

6. Belay ED, Bresee JS, Holman RC, Khan AS, Shahriari A, Schonberger LB. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med. 1999. 340:1377–1382.

7. Bang JS, Nam SJ, Lee KH, Bae EJ, Park WI, Lee HS, et al. Reye syndrome after acute enteritis during the neonatal period. Korean J Pediatr. 2006. 49:273–277.

8. Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, et al. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology. 1992. 39:542–545.

9. Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol. 2008. 20:1064–1070.

10. O'Brien M, Parness IA, Neufeld EJ, Baker AL, Sundel RP, Newburger JW. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease. Pediatrics. 2000. 105:E64.

11. Takahashi M, Mason W. Kawasaki syndrome, Reye syndrome, and aspirin. Pediatrics. 1986. 77:616–617.

12. Lee JH, Hung HY, Huang FY. Kawasaki disease with Reye syndrome: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992. 33:67–71.

13. Park JH, Kim WS, Hahn YS, Park BS, Han HS. A case of Reye-like syndrome combined with Kawasaki disease. J Korean Child Neurol Soc. 2000. 8:333–336.

14. Orlowski JP. Whatever happened to Reye's syndrome? Did it ever really exist? Crit Care Med. 1999. 27:1582–1587.

15. Kim JG, Yun CK, Ko KW. Statistical analysis for the mortality of in-patient in pediatric ward. J Korean Pediatr Soc. 1977. 20:933–942.

16. Lovejoy FH Jr, Smith AL, Bresnan MJ, Wood JN, Victor DI, Adams PC. Clinical staging in Reye syndrome. Am J Dis Child. 1974. 128:36–41.